Skip to main content
. 2023 Jan 21;21:40. doi: 10.1186/s12967-022-03860-3

Table 2.

Patient and tumour characteristics for proteomics validation

TFC (n = 12) PCa (n = 17) CRPC (n = 15)
Age (years)
 Median (range) 66.5 (46–77) 70.5 (53–83) 71 (55–83)
Baseline PSA (ng/mL)
 Median (range) 10.08 (0.13–149) 120 (5.9–137.9)
Local treatment, n (%)
 Radical prostatectomy 15 (88.2%)
 Endocrinotherapy 8 (53.33%)